KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Share-based Compensation (2016 - 2026)

Abbott Laboratories' Share-based Compensation history spans 18 years, with the latest figure at $317.0 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 9.69% to $317.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $692.0 million, a 5.17% increase, with the full-year FY2025 number at $664.0 million, down 1.34% from a year prior.
  • Share-based Compensation hit $317.0 million in Q1 2026 for Abbott Laboratories, up from $113.0 million in the prior quarter.
  • Over the last five years, Share-based Compensation for ABT hit a ceiling of $317.0 million in Q1 2026 and a floor of $111.0 million in Q4 2024.
  • Historically, Share-based Compensation has averaged $175.5 million across 5 years, with a median of $132.0 million in 2023.
  • Biggest five-year swings in Share-based Compensation: dropped 7.87% in 2023 and later grew 9.69% in 2026.
  • Tracing ABT's Share-based Compensation over 5 years: stood at $115.0 million in 2022, then dropped by 0.87% to $114.0 million in 2023, then decreased by 2.63% to $111.0 million in 2024, then grew by 1.8% to $113.0 million in 2025, then soared by 180.53% to $317.0 million in 2026.
  • Business Quant data shows Share-based Compensation for ABT at $317.0 million in Q1 2026, $113.0 million in Q4 2025, and $120.0 million in Q3 2025.